Molecular Skin Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
3
Molecular Skin Therapeutics General Information
Description
Provider of skin therapeutic services based in Palo Alto, California. The company's biotechnology services are focused on skin therapy focused on developing BBP-561, a series of topical KLK5/7 inhibitors, for the treatment of Netherton Syndrome.
Contact Information
Corporate Office
- 165 University Avenue
- Suite 5
- Palo Alto, CA 94301
- United States
Corporate Office
- 165 University Avenue
- Suite 5
- Palo Alto, CA 94301
- United States
Molecular Skin Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Molecular Skin Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Molecular Skin Therapeutics Patents
Molecular Skin Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4037687-A1 | Benzoxazinone compounds as klk5/7 dual inhibitors | Pending | 01-Oct-2019 | ||
| CA-3151626-A1 | Benzoxazinone compounds as klk5/7 dual inhibitors | Pending | 01-Oct-2019 | ||
| AU-2020359526-A1 | Benzoxazinone compounds as klk5/7 dual inhibitors | Pending | 01-Oct-2019 | ||
| US-20210101911-A1 | Benzoxazinone compounds as klk5/7 dual inhibitors | Active | 01-Oct-2019 | ||
| EP-4037687-A4 | Benzoxazinone compounds as klk5/7 dual inhibitors | Pending | 01-Oct-2019 | C07D498/04 |
Molecular Skin Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Molecular Skin Therapeutics FAQs
-
Where is Molecular Skin Therapeutics headquartered?
Molecular Skin Therapeutics is headquartered in Palo Alto, CA.
-
What industry is Molecular Skin Therapeutics in?
Molecular Skin Therapeutics’s primary industry is Biotechnology.
-
Is Molecular Skin Therapeutics a private or public company?
Molecular Skin Therapeutics is a Private company.
-
What is Molecular Skin Therapeutics’s current revenue?
The current revenue for Molecular Skin Therapeutics is .
-
How much funding has Molecular Skin Therapeutics raised over time?
Molecular Skin Therapeutics has raised $2.7M.
-
Who are Molecular Skin Therapeutics’s investors?
BridgeBio Pharma has invested in Molecular Skin Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
